Jiangsu Hengrui Medicine
600276.SS
#526
Rank
โ‚น3.404 T
Marketcap
โ‚น533.64
Share price
0.02%
Change (1 day)
15.84%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น7.87. In 2022 the company made an earnings per share (EPS) of โ‚น7.85 a decrease over its 2021 EPS that were of โ‚น9.46.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-4.94%
2022โ‚น7.85-17.1%
2021โ‚น9.46-24.44%
2020โ‚น12.5320.3%
2019โ‚น10.4125.58%
2018โ‚น8.2927.55%
2017โ‚น6.5021.64%
2016โ‚น5.3413.57%
2015โ‚น4.7139.86%
2014โ‚น3.3621.33%
2013โ‚น2.7717.7%
2012โ‚น2.3625.56%
2011โ‚น1.8826.22%
2010โ‚น1.4910.3%
2009โ‚น1.3557.92%
2008โ‚น0.8511.06%
2007โ‚น0.7785.81%
2006โ‚น0.4187.94%
2005โ‚น0.2233.97%
2004โ‚น0.1629.78%
2003โ‚น0.1319.78%
2002โ‚น0.11